"Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial" from Meyhöfer et al. published in May in Nat Med https://t.co/qnksZhZYud #LPoM#lipodystrophy
"Assessment of bone density and microarchitecture in patients with familial partial lipodystrophy" from Gonçalves Muniz et al. published this month in Front Endocrinol (Lausanne) https://t.co/QBm1FhbTrZ #LPoM#lipodystrophy
"Progerin cross-linking stiffens the nucleus and impairs mechanosensation in Hutchinson-Gilford progeria syndrome" from Srivastava et al. published this month in J Cell Sci https://t.co/bHNsf6kJiq #LPoM#lipodystrophy
"Long-term outcomes and prognostic factors in juvenile dermatomyositis: A systematic review of studies with more than 12 months of follow-up" from Scagnellato et al. published this month in Autoimmun Rev https://t.co/8uvEq3anrL #LPoM#lipodystrophy
"Vimentin molecular linkages with nesprin-3 enhance nuclear deformations by cell geometric constraints" from Swoger et al. published this month in Sci Rep https://t.co/z3N61jMhAM #LPoM#lipodystrophy
"Lamin A depletion and RSG influence PPARγ DNA binding and chromatin organization in murine adult fibroblast cells" from Sen et al. published this month in Biophys J https://t.co/Wi9VhgPMzq #LPoM#lipodystrophy
"Lipidomics analysis to assess metabolic complications in familial partial lipodystrophy type 2" from Koue-Chon-Lim et al. published this month in Diabetes Res Clin Pract https://t.co/uxSW1CaHri #LPoM#lipodystrophy
"Exceptional longevity modifying allele APOE2 promotes DNA signaling pathways resisting cellular senescence in human neurons" from Gerónimo-Olvera et al. published this month in Aging Cell https://t.co/yY5BQE1pa4 #LPoM#lipodystrophy
"Clinical, genetics and in silico analysis of a novel BSCL2 variant in a patient with CGL2 from Iranian Azeri Turkish ethnic group: expanding the genotypic spectrum ..." from Bazmi et al. published this month in Hum Genome Var
https://t.co/uAoFrgKUZ9 #LPoM#lipodystrophy
"Hutchinson-Gilford Progeria Syndrome: Genetic insights, clinical challenges, and innovative therapeutic approaches" from Raj et al. published this month in Curr Gene Ther https://t.co/jjt98kvshR #LPoM#lipodystrophy
"Seipin-defined ER sites undergo distinct enrichment of factors for the biogenesis of sterol ester rich lipid droplets" from Khatri et al. published in April 2026 in iScience https://t.co/oZ6N6P4Sqj #LPoM#lipodystrophy
"Impact of juvenile dermatomyositis on growth, puberty, bone mineral density, and body composition in children" from Sudhera et al. published in March 2026 in Mediterr J Rheumatol https://t.co/V8Pk7I4k3E #LPoM#lipodystrophy
"Bone phenotype in familial partial lipodystrophy type 2: insulin resistance and sclerostin" from Dupuis et al. published this month in Diabetes Metab https://t.co/odGGcOZQAM #lipodystrophy
"Familial partial lipodystrophy type 2 associated with a novel LMNA variant (c.604G>C; p.Glu202Gln): a Colombian family case series" from Mendoza et al. published this month in Front Endocrinol (Lausanne)
https://t.co/hV2PsDvPKP #LPoM#lipodystrophy
“Gene therapy for aging: Current evidence and future directions” from Zhang et al. published this month in Ageing Res Rev https://t.co/Fy0J5Io3y1 #LPoM#lipodystrophy
“White adipose atrophy exacerbates cold stress and accelerates aging in male mice” from Liu et al. published this month in Nat Commun https://t.co/ZQB9lxmkxX #LPoM#lipodystrophy
“Farnesylated prelamin A induces fibroblast polarity defects in premature aging disorders by inhibiting nesprin-2-SUN2 LINC complex function” from Lio et al. published this month in J Cell Sci https://t.co/c0QBRx3d5e #LPoM#lipodystrophy
“Lipodystrophy look-alikes: navigating diagnostic overlap with endocrine diseases” from Ceccarini et al. published this month in Eur J Endocrinol https://t.co/HbkQbW7thr #lipodystrophy
“Genotype-first approach reveals monogenic lipodystrophy is underdiagnosed, with health and mortality risks” from Sharp et al. published this month in EBioMedicine https://t.co/PI5W9eTHwL #lipodystrophy
“A novel PPARG R212W variant causes familial partial lipodystrophy type 3: clinical presentation and functional characterization” from Gao et al. published in February in Int J Mol Sci https://t.co/7FUAM5Se4H
#LPoM#lipodystrophy